Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome

Background: Hemolytic uremic syndrome (HUS) is a complex disease with multi-organ involvement. Eculizumab therapy is recommended for treatment of complement mediated hemolytic uremic syndrome (cHUS). However, there are few studies evaluating eculizumab therapy among children with HUS. The primary ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranabothu, Saritha, Brown, Clare C., Blaszak, Richard, Millner, Rachel, Moore, Kristen Rice, Prodhan, Parthak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523981/
https://www.ncbi.nlm.nih.gov/pubmed/34676187
http://dx.doi.org/10.3389/fped.2021.733042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523981/
https://www.ncbi.nlm.nih.gov/pubmed/34676187
http://dx.doi.org/10.3389/fped.2021.733042

Ejemplares similares